Home
 /
Papers
 /
Microbiology
 /
In situ chromatin dynamics and HIV-1 nuclear trafficking
Preprint
Open access
V1
Top 1% · Validated by QED

In situ chromatin dynamics and HIV-1 nuclear trafficking

Zhen Hou, Yao Shen, Long Chen +3 more
January 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.12.693995
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By resolving nucleosomes at 5.6 Å inside intact nuclei and directly showing CPSF6-coated HIV-1 cores displace chromatin during penetration, this work converts nuclear trafficking from biochemical inference to structural reality—redefining how large complexes navigate heterogeneous nuclear architecture.

QED claims analysis

Summary

In situ cryo-electron tomography reveals that HIV-1 cores navigate the nucleus by locally excluding nucleosomes within ~35 nm and preferentially associating with open chromatin conformations, a process that requires CPSF6 binding to the viral capsid to enable passage through peripheral heterochromatin toward transcriptionally active nuclear interior regions, establishing a structural framework linking chromatin dynamics to viral nuclear trafficking and integration site targeting.

See full analysis
Main Claim 1 –

Correlative cryo-ET Visualizes HIV-1 Cores Trafficking in Nuclei

Main Claim 2 –

Four In Situ Nucleosome Structural Classes Show Spatial Heterogeneity

Supporting evidence

  • Nuclear Chromatin Forms Irregular Zigzag Nucleosome Arrays, Not 30-nm Fibers
Main Claim 3 –

HIV-1 Cores Exclude Nucleosomes and Prefer Open Chromatin

Main Claim 4 –

CPSF6 Binding Enables HIV-1 Nuclear Trafficking and Chromatin Preference

Supporting evidence

  • CPSF6 Guides HIV-1 Cores Through Peripheral Heterochromatin to Interior

Abstract

The organization and dynamics of chromatin within intact nuclei remain poorly defined, limiting understanding of how nuclear architecture influences macromolecular transport. HIV-1 provides a striking example of a large complex that must traverse this dynamic landscape to access integration sites within transcriptionally active regions. Here, we combine a functional nuclear import system with correlative cryo-electron tomography to visualize chromatin architecture and HIV-1 cores in situ during nuclear penetration. Native nucleosomes resolved at 5.6 Å reveal four structural classes, from compact conformations at the nuclear periphery to open, flexible forms in the interior, defining a spatially heterogeneous and dynamic chromatin landscape. Within this environment, HIV-1 cores decorated with nuclear factors exclude nearby nucleosomes and preferentially associate with open chromatin. Disruption of CPSF6–capsid interactions abolishes these associations, confining viral cores to peripheral chromatin. These findings establish an in situ framework linking chromatin structure and dynamics to HIV-1 nuclear trafficking and provide a structural basis for viral navigation within the dynamic nuclear landscape.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?